• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. SILK SUTURE 18"(45CM) 4-0 BLK; SUTURE, NONABSORBABLE, SILK

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. SILK SUTURE 18"(45CM) 4-0 BLK; SUTURE, NONABSORBABLE, SILK Back to Search Results
Catalog Number 683G
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 02/20/2019
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
(b)(4).Attempts have been made to retrieve the device.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.
 
Event or Problem Description
It was reported that the patient underwent dental flap surgery procedure on an (b)(6) 2019 and suture was used.It was reported that the needle was broken at the swage part during interrupted suturing on the gum.The swage part was not held.When pulling the suture after the suturing, the suture had been detached from the needle.No broken pieces of the needle were left inside the patient¿s body.There were no adverse consequences to the patient.
 
Additional Manufacturer Narrative
Product complaint #
=
> (b)(4).A manufacturing record review was performed for the finished device lot and no non-conformances were identified.
 
Additional Manufacturer Narrative
(b)(4).Investigation summary: it was reported performance needle breakage.A failed suture needle was submitted for fractographic evaluation.A fracture was observed at the suture attachment of the needle.The needle was received in two pieces, only one of the mating fracture surfaces was examined for this evaluation.A microscope was used to examine the fracture surfaces and surrounding area of the needle.The fracture surfaces were examined in multiple locations in order to determine the fracture mode.The evaluation revealed the fracture was composed of microvoid coalescence, which is evidence of a ductile overload failure.Mechanical damage observed coincidental to the fracture provides additional evidence that the failure was induced by mechanical deformation leading to ductile overload.This was a ductile fracture.The manufacturing records were reviewed, and the manufacturing/packaging criteria were met prior to the release of this batch.The evidence of this examination indicates that the breakage occurred at the attachment area of the needle during use due to tensile overload.There is no evidence of any material flaw or defect that would cause premature failure.In order to avoid this kind of damage grasp the needle in an area one-third (1/3) to one-half (1/2) of the distance from the attachment end to the point.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SILK SUTURE 18"(45CM) 4-0 BLK
Common Device Name
SUTURE, NONABSORBABLE, SILK
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876 0151
MDR Report Key8425842
Report Number2210968-2019-79517
Device Sequence Number14013745
Product Code GAP
UDI-Device Identifier10705031008175
UDI-Public10705031008175
Combination Product (Y/N)N
Initial Reporter CountryJA
PMA/510(K) Number
K946173
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup
Report Date (Section B) 02/20/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2023
Device Catalogue Number683G
Device Lot NumberMCQ286
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/09/2019
Initial Date Received by Manufacturer 02/20/2019
Supplement Date Received by Manufacturer02/20/2019
04/09/2019
Initial Report FDA Received Date03/15/2019
Supplement Report FDA Received Date03/29/2019
05/06/2019
Patient Sequence Number1
-
-